immunotherapy delivered by blinatumomab improves survival in acute lymphoblastic leukemia patients
Published 8 years ago • 248 plays • Length 4:35Download video MP4
Download video MP3
Similar videos
-
3:04
immunotherapy for frontline treatment of all: inotuzumab ozogamicin and blinatumomab
-
1:24
immunotherapy with blinatumomab vs chemotherapy in pediatric patients with newly diagnosed b-all
-
3:09
challenges with immunotherapy in all
-
2:39
the future of immunotherapy for the treatment of all
-
7:40
immunotherapy for aml and all: checkpoint inhibitors & car t-cells for b-cell all
-
3:36
bite® immunotherapy: the next generation of cancer treatment
-
6:11
first-in-human study of the menin-kmt2a inhibitor jnj-75276617 in r/r acute leukemias
-
3:13
which cancers can be treated with immunotherapy? ask a scientist
-
1:15
an exciting era for immunotherapy for r/r all
-
2:24
the success of phase iii tower trial of blinatumomab in all
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
1:33
addressing the potential role of immunotherapy in the frontline treatment of all
-
4:36
promising results for blinatumomab in younger relapsed b-all
-
3:47
the role of immunotherapy in the aml treatment landscape
-
2:00
an overview of immunotherapies for leukemia
-
1:37
genomic determinants of response to blinatumomab
-
2:44
promising results for blinatumomab in younger b-all at first relapsed
-
11:19
immunotherapy for aml & all
-
1:22
all: recent immunotherapeutic developments
-
2:37
the addition of inotuzumab ozogamicin to hyper-cvad blinatumomab in patients with b-all
-
2:24
novel all treatment strategies: blinatumomab
-
1:03
using bispecific antibodies instead of chemotherapy to reach pre-transplant remission in b-all